Toggle Main Menu Toggle Search

Open Access padlockePrints

Using the precaution adoption process model to understand decision-making about the COVID-19 booster vaccine in England

Lookup NU author(s): Louis Goffe, Dr Fiona GrahamORCiD, Dr Mei Yee TangORCiD, Jan Lecouturier, Professor Falko Sniehotta

Downloads


Licence

This work is licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0).


Abstract

© 2023 The AuthorsBackground: COVID-19 continues to pose a threat to public health. Booster vaccine programmes are critical to maintain population-level immunity. Stage theory models of health behaviour can help our understanding of vaccine decision-making in the context of perceived threats of COVID-19. Purpose: To use the Precaution Adoption Process Model (PAPM) to understand decision-making about the COVID-19 booster vaccine (CBV) in England. Methods: An online, cross-sectional survey informed by the PAPM, the extended Theory of Planned Behaviour and Health Belief Model administered to people over the age of 50 residing in England, UK in October 2021. A multivariate, multinomial logistic regression model was used to examine associations with the different stages of CBV decision-making. Results: Of the total 2,004 participants: 135 (6.7%) were unengaged with the CBV programme; 262 (13.1%) were undecided as to whether to have a CBV; 31 (1.5%) had decided not to have a CBV; 1,415 (70.6%) had decided to have a CBV; and 161 (8.0%) had already had their CBV. Being unengaged was positively associated with beliefs in their immune system to protect against COVID-19, being employed, and low household income; and negatively associated with CBV knowledge, a positive COVID-19 vaccine experience, subjective norms, anticipated regret of not having a CBV, and higher academic qualifications. Being undecided was positively associated with beliefs in their immune system and having previously received the Oxford/AstraZeneca (as opposed to Pfizer/BioNTech) vaccine; and negatively associated with CBV knowledge, positive attitudes regarding CBV, a positive COVID-19 vaccine experience, anticipated regret of not having a CBV, white British ethnicity, and living in East Midlands (vs London). Conclusions: Public health interventions promoting CBV may improve uptake through tailored messaging directed towards the specific decision stage relating to having a COVID-19 booster.


Publication metadata

Author(s): Meyer C, Goffe L, Antonopoulou V, Graham F, Tang MY, Lecouturier J, Grimani A, Chadwick P, Sniehotta FF

Publication type: Article

Publication status: Published

Journal: Vaccine

Year: 2023

Volume: 41

Issue: 15

Pages: 2466-2475

Print publication date: 06/04/2023

Online publication date: 17/02/2023

Acceptance date: 13/02/2023

Date deposited: 30/03/2023

ISSN (print): 0264-410X

ISSN (electronic): 1873-2518

Publisher: Elsevier Ltd

URL: https://doi.org/10.1016/j.vaccine.2023.02.047

DOI: 10.1016/j.vaccine.2023.02.047


Altmetrics

Altmetrics provided by Altmetric


Funding

Funder referenceFunder name
PR-PRU1217-20501

Share